Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes
- PMID: 14576823
- DOI: 10.1038/sj.onc.1207129
Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes
Abstract
Mammary epithelial regeneration implies the existence of cellular progenitors with retained replicative capacity, prolonged lifespan and developmental potency. Evidence exists that deltaN-p63 isoforms preserve these features by modulating p53 activity in basal epithelia. deltaN-p63 mRNA levels decline at the onset of differentiation suggesting that its transcriptional regulation may contribute to the initiation of differentiation. To study transcriptional regulation of deltaN-p63, a 10.3 kbp fragment containing the deltaN-p63 promoter was isolated. We report here that deltaN-p63 is a positive and negative transcriptional target of p53 and deltaN-p63-alpha, respectively. Disruption of p53 activity or expression abolishes the expression of deltaN-p63-alpha. This regulation is mediated by a p53-binding element sufficient to confer these activities to a heterologous promoter. Chromatin immune-precipitation indicates that, in asynchronously growing cells, p53 occupies this element. In response to DNA damage, deltaN-p63-alpha is recruited to this element as transcription of deltaN-p63 declines. Disruption of deltaN-p63-alpha expression had differential effects on the transcriptional regulation of several p53-target genes. These findings indicate that p53 contributes to the preservation of basal epithelia by driving the expression of deltaN-p63 isoforms. These studies also suggest that in response to genotoxic stress, deltaN-p63-alpha mediates the silencing of its own promoter thereby altering the pattern of p53-target gene expression.
Similar articles
-
TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.Oncogene. 2006 Apr 13;25(16):2349-59. doi: 10.1038/sj.onc.1209270. Oncogene. 2006. PMID: 16331262
-
Differential recognition of response elements determines target gene specificity for p53 and p63.Mol Cell Biol. 2005 Jul;25(14):6077-89. doi: 10.1128/MCB.25.14.6077-6089.2005. Mol Cell Biol. 2005. PMID: 15988020 Free PMC article.
-
Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.Cancer Res. 1999 Dec 1;59(23):5908-11. Cancer Res. 1999. PMID: 10606233
-
IRES mediated translational regulation of p53 isoforms.Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):131-9. doi: 10.1002/wrna.1202. Epub 2013 Nov 7. Wiley Interdiscip Rev RNA. 2014. PMID: 24343861 Review.
-
Gene regulatory mechanisms orchestrated by p63 in epithelial development and related disorders.Biochim Biophys Acta. 2015 Jun;1849(6):590-600. doi: 10.1016/j.bbagrm.2015.03.003. Epub 2015 Mar 19. Biochim Biophys Acta. 2015. PMID: 25797018 Review.
Cited by
-
Long-term expansion of directly reprogrammed keratinocyte-like cells and in vitro reconstitution of human skin.J Biomed Sci. 2020 Apr 20;27(1):56. doi: 10.1186/s12929-020-00642-1. J Biomed Sci. 2020. PMID: 32312260 Free PMC article.
-
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.J Exp Med. 2013 Mar 11;210(3):581-603. doi: 10.1084/jem.20121439. Epub 2013 Feb 18. J Exp Med. 2013. PMID: 23420876 Free PMC article.
-
Pathway Regulation of p63, a Director of Epithelial Cell Fate.Front Endocrinol (Lausanne). 2015 Apr 28;6:51. doi: 10.3389/fendo.2015.00051. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 25972840 Free PMC article. Review.
-
p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation.PLoS One. 2012;7(7):e41742. doi: 10.1371/journal.pone.0041742. Epub 2012 Jul 24. PLoS One. 2012. PMID: 22911849 Free PMC article.
-
A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteins.Int J Nanomedicine. 2014 Apr 10;9:1799-813. doi: 10.2147/IJN.S58465. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24748790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous